Showing results (141-150 of 166) with videos related to
Sort By:
Pageof 17
The American Journal of Medicine|December 1, 1988
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatmentD D Hurd, T W LeBien, L C Lasky, et al.Journal of the Society for Integrative Oncology|March 13, 2014
Music for patients with hematological malignancies undergoing bone marrow biopsy: a randomized controlled study of anxiety, perceived pain, and patient satisfactionSuzanne C Danhauer, Tanya Vishnevsky, Cassie R Campbell, et al.The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2020
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin LymphomaLauren Shea, Marcus P Watkins, Fei Wan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909Lloyd E Damon, Jeffrey L Johnson, Donna Niedzwiecki, et al.The Journal of Community and Supportive Oncology|August 20, 2015
Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106Kathryn M Greven, L Douglas Case, Lawrence R Nycum, et al.Annals of Internal Medicine|July 18, 2002
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trialJames E Peacock, Deirdre A Herrington, James C Wade, et al.Leukemia & Lymphoma|August 15, 2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)Francis J Giles, Carole B Miller, David D Hurd, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13William P Peters, Gary L Rosner, James J Vredenburgh, et al.Pageof 17